Increased PD-L1 expression in erlotinib-resistant NSCLC cells with MET gene amplification is reversed upon MET-TKI treatment.
published in: Oncotarget
date of publication: 2017-08-04
language: English
main subject: non-small-cell lung carcinoma
Cites articles 33
Date
Title
Article - wd:Q41998799